JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021 (Journal Indexed in SCI)
Article / Article
Title of Journal :
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
What is known and objective: Patients with ovarian cancer have not benefited substantially from immunotherapy. We report a case of ovarian cancer, however, that responded well to the programmed cell death-ligand 1 inhibitor atezolizumab.